fluphenazine has been researched along with diazepam in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (68.75) | 18.7374 |
| 1990's | 3 (9.38) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andrasik, F; Hughes, JR; Ollendick, TH; Turner, SM | 1 |
| Ashton, H; Millman, JE; Telford, R; Thompson, JW | 1 |
| Henry, BW; Overall, JE; Woodward, JA | 1 |
| Hicks, TP; Oka, JI | 1 |
| Dubnitskaia, EB; Maksimov, VI; Novikov, VN; Smulevich, AB; Vorob'ev, VIu | 1 |
| Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP | 1 |
| Dencker, SJ; Frankenberg, K; Malm, U; Zell, B | 1 |
| Gouret, C; Raynaud, G | 1 |
| Glegg, AM; Turner, P | 1 |
| Pigott, PV | 1 |
| Ayd, FJ | 1 |
| Nymark, M | 1 |
| Soyka, D | 1 |
| Diemath, HE; Enge, S; Lechner, H | 1 |
| Garriott, JC; Stolman, A | 1 |
| Dally, P | 1 |
| Langner, E | 1 |
| Cohen, MM; Frosch, WA; Hirschhorn, K | 1 |
| Da Vanzo, JP; Daugherty, M; Kang, L; Ruckart, R | 1 |
| Mori, J; Satoh, H; Satoh, Y | 1 |
| Jones, RS; Olpe, HR | 1 |
| Dorevitch, A; Durst, R; Fraenkel, Y | 1 |
| Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B | 1 |
| INVERNIZZI, G | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
2 review(s) available for fluphenazine and diazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Preparations; Depression; Diazepam; Drug Interactions; Eye Manifestations; Fatty Acids; Female; Fluphenazine; Humans; Jaundice; Male; Mental Disorders; Movement Disorders; Parkinson Disease, Secondary; Schizophrenia; Seizures; Skin Manifestations | 1974 |
5 trial(s) available for fluphenazine and diazepam
| Article | Year |
|---|---|
A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal subjects.
Topics: Blood Pressure; Central Nervous System; Contingent Negative Variation; Diazepam; Drug Combinations; Female; Fluphenazine; Heart Rate; Humans; Male; Nortriptyline; Reaction Time | 1978 |
A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Diazepam; Drug Evaluation; Female; Fluphenazine; Humans; Imipramine; Injections; Male; Middle Aged; Palmitic Acids; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Sulfonamides; Time Factors | 1973 |
A review of clinical studies with combinations of fluphenazine and nortriptyline.
Topics: Amitriptyline; Anxiety; Central Nervous System; Clinical Trials as Topic; Depression; Diazepam; Doxepin; Drug Combinations; Fluphenazine; Heart Conduction System; Humans; Motor Activity; Nortriptyline; Perphenazine; Placebos; Psychiatric Status Rating Scales; Vision Disorders | 1972 |
[The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus].
Topics: Amitriptyline; Apomorphine; Aporphines; Barbiturates; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Diazepam; Dimenhydrinate; Eye Movements; Fluphenazine; Haloperidol; Humans; Imipramine; Schizophrenia; Thioridazine; Triflupromazine | 1968 |
Diazepam treatment of early signs of exacerbation in schizophrenia.
Topics: Acute Disease; Adult; Age of Onset; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
25 other study(ies) available for fluphenazine and diazepam
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Pharmacological treatment of aggressive behavior and emesis in the Cornelia de Lange Syndrome.
Topics: Adult; Aggression; Chlorpromazine; De Lange Syndrome; Diazepam; Drug Therapy, Combination; Fluphenazine; Humans; Male; Vomiting | 1979 |
Patterns of symptom change in anxious depressed outpatients treated with different drugs.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Depression; Desipramine; Diazepam; Drug Combinations; Fluphenazine; Humans; Imipramine; Mental Disorders; Nortriptyline; Perphenazine; Thioridazine; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1975 |
Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex.
Topics: Animals; Anti-Anxiety Agents; Bicuculline; Cats; Diazepam; Electric Stimulation; Electrophysiology; Female; Flumazenil; Fluphenazine; gamma-Aminobutyric Acid; Male; Midazolam; Physical Stimulation; Somatosensory Cortex; Space Perception; Synapses | 1990 |
[Intensive psychopharmacologic therapy of slowly-progressive schizophrenia].
Topics: Adult; Antipsychotic Agents; Chlordiazepoxide; Diazepam; Female; Fluphenazine; Humans; Infusions, Parenteral; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Syndrome; Trimeprazine | 1985 |
Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
Topics: Administration, Oral; Adult; Diazepam; Drug Therapy, Combination; Fluphenazine; Humans; Injections, Intramuscular; Male; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid | 1988 |
[Activity of various neuroleptics after single repeated treatment in the mice submitted to the four plate test and the escape test].
Topics: Animals; Chlorpromazine; Chlorprothixene; Diazepam; Drug Evaluation, Preclinical; Electroshock; Escape Reaction; Fluphenazine; Haloperidol; Methotrimeprazine; Mice; Perphenazine; Phenothiazines; Prochlorperazine; Thioridazine; Tranquilizing Agents; Trifluperidol | 1974 |
Pharmacological studies of fluphenazine and nortriptyline in combination in man.
Topics: Adolescent; Adult; Analysis of Variance; Behavior; Central Nervous System; Diazepam; Female; Flicker Fusion; Fluphenazine; Humans; Male; Nortriptyline; Reaction Time; Saliva; Statistics as Topic | 1971 |
Apomorphine provoked stereotype in the dog.
Topics: Amitriptyline; Animals; Anisoles; Apomorphine; Atropine; Behavior, Animal; Benzamides; Benztropine; Diazepam; Diphenhydramine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Ethylamines; Female; Fluphenazine; Haloperidol; Humans; Male; Methyltyrosines; Motor Activity; Phenoxybenzamine; Piperazines; Receptors, Drug; Scopolamine; Stereotyped Behavior; Xanthenes | 1972 |
EEG depth leads during stereotaxic brain surgery. A report on 117 cases (5 target points, effects of 13 different drugs).
Topics: Amides; Amygdala; Antimetabolites; Asparagine; Benzoates; Brain; Brain Diseases; Cerebrovascular Circulation; Child; Chlordiazepoxide; Diazepam; Dihydroxyphenylalanine; Electroencephalography; Female; Fluphenazine; Gyrus Cinguli; Hippocampus; Humans; Hyperkinesis; Male; Methanol; Middle Aged; Parkinson Disease; Pyridines; Pyridoxine; Spasm; Stereotaxic Techniques; Thalamic Nuclei; Theophylline; Tranquilizing Agents; Triflupromazine; Vasodilator Agents | 1970 |
Detection of some psychotherapeutic drugs and their metabolites in urine.
Topics: Amitriptyline; Amphetamine; Analgesics; Antidepressive Agents; Chlordiazepoxide; Chlorpromazine; Chromatography, Thin Layer; Desipramine; Diazepam; Fluphenazine; Haloperidol; Humans; Imipramine; Indicators and Reagents; Methadone; Perphenazine; Solvents; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1971 |
The present status of psychotropic drugs.
Topics: Antidepressive Agents; Chlormethiazole; Diazepam; Dibenzazepines; Fluphenazine; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Monoamine Oxidase Inhibitors; Neurotic Disorders; Propranolol; Schizophrenia | 1970 |
[Management of psychotic drive disorders].
Topics: Adult; Bipolar Disorder; Chlorprothixene; Diazepam; Drive; Female; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Paranoid Disorders; Psychotic Disorders; Schizophrenia; Thioridazine; Tranylcypromine; Trifluoperazine | 1968 |
Cytogenetic effects of tranquilizing drugs in vivo and in vitro.
Topics: Adolescent; Adult; Child; Chlordiazepoxide; Chlorpromazine; Chromosome Aberrations; Culture Techniques; Diazepam; Female; Fluphenazine; Humans; Leukocytes; Male; Middle Aged; Thioridazine; Time Factors; Tranquilizing Agents | 1969 |
Pharmacological and biochemical studies in isolation-induced fighting mice.
Topics: Aggression; Amitriptyline; Amphetamine; Analgesics; Animals; Anticonvulsants; Antidepressive Agents; Atropine; Behavior; Chlorpromazine; Diazepam; Fluphenazine; Humans; Hypnotics and Sedatives; Imipramine; Learning; Male; Meprobamate; Mice; Plants, Medicinal; Rauwolfia; Social Isolation; Tranquilizing Agents | 1966 |
Effect of zotepine and various drugs on apomorphine- and methamphetamine-induced rotational behaviour in rats with unilateral lesions of the substantia nigra.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Atropine; Behavior, Animal; Diazepam; Dibenzothiepins; Fluphenazine; Haloperidol; Male; Methamphetamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1983 |
An increase in sensitivity of rat cingulate cortical neurones to substance P occurs following withdrawal of chronic administration of antidepressant drugs.
Topics: Action Potentials; Animals; Antidepressive Agents; Clomipramine; Desipramine; Diazepam; Drug Resistance; Fluphenazine; Gyrus Cinguli; Male; Neurons; Rats; Substance P; Time Factors; Trimipramine; Zimeldine | 1984 |
Platelet dysfunction associated with clozapine therapy.
Topics: Amobarbital; Blood Cell Count; Clozapine; Delayed-Action Preparations; Diazepam; Drug Monitoring; Drug Therapy, Combination; Epistaxis; Fluphenazine; Hemoglobins; Humans; Male; Middle Aged; Platelet Count; Schizophrenia, Paranoid; Thrombocytopenia | 1993 |
[OBSERVATIONS ON THE USE OF PHENYLPYRROLIDINOPENTANE AS AN ANTIASTHENIC AGENT IN TREATMENT WITH PSYCHOPHARMACOLOGICAL DRUGS].
Topics: Amitriptyline; Anxiety; Anxiety Disorders; Asthenia; Bipolar Disorder; Chemical and Drug Induced Liver Injury; Chlorpromazine; Depression; Diazepam; Fluphenazine; Hepatitis; Mental Disorders; Monoamine Oxidase Inhibitors; Neurotic Disorders; Promazine; Psychopharmacology; Schizophrenia; Sympathomimetics; Toxicology; Tranquilizing Agents | 1964 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |